Willow Rheumatology Wellness

Willowbrook, Illinois 60527

3 studies enrolling now · 6 studies all time

What they study most

Autoimmunity, Inflammation, Giant Cell Arteritis, Polymyalgia Rheumatica, Primary Sjogren's Disease, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE)

Studies at this site

• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease — Recruiting now
• A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants — Recruiting now
• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Recruiting now
• Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) — Running, not enrolling
• Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR — Completed